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Classical genetic studies have shown that the human complement components
C2, C4, and factor B are encoded by closely linked genes within the MHC. This
is also the case in all other mammalian species studied and, for this reason, these
genes are referred to as the class III genes of the MHC (1, 2) . In the mouse, the
C3 locus has been mapped 10-12 cM telomeric to the MHC (3) but in man C3
maps on a different chromosome (4) . Similarly, we have shown that the genes
encoding the regulatory complement components C4-binding protein (C4bp),
C3b/C4b receptor (CR1) and factor H (H) are closely linked in humans (5, 6) .
We have designated this linkage group as regulator of complement activation
(RCA)' and have shown that it segregates independently of the class III gene
cluster located on human chromosome 6 (6) . Recently, in situ hybridization
experiments using a CR1 cDNA probe have provided a chromosomal location
for the RCA gene cluster on the long arm of human chromosome 1 (7) . C2,
factor B, C4bp, H, and CR 1 are all members of a newly recognized family of
proteins that bind C3b and/or C4b and show a particular structural organization
based on the presence of internal repeat units of ^-60 amino acids that share a
framework of highly conserved residues (8) . These homologies support the
concept that these proteins originated from a common evolutionary ancestor .
The demonstratipn, however, of the existence of two separate linkage groups,
one encoding the components of the C3-convertases, C2, C4, and factor B, and
the other encoding the regulators of the C3-convertases, C4bp, H, and CR1,
suggests that the encoding of these proteins in two separate gene clusters may
relate to their specific roles in the complement cascade . How the class III and
the RCA gene clustersdeveloped throughthe evolution of the vertebrate animals
remains, however, to be determined .
The decay-accelerating factor (DAF) is a membrane glycoprotein similar to
C4bp, CR 1, and H in that it binds C3b or C4b inhibiting the formation of the
C3-convertases (9, 10) . DAF, however, does notact as acofactor for the cleavage
This work was supported in part by grant DK 19631-11 from the National Institutes of Health, and
by a grantfrom the Sallyand Alta Solomon Foundation .
' Abbreviations used in this paper:
￿
DAF, decay-accelerating factor ; RCA, regulator of complement
activation ; RFLP, restriction fragment length polymorphism .
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of Cab and C4b by factor I (11). Erythrocytes from patients with paroxysmal
nocturnal hemoglobinuria (PNH), an acquired disease characterized by intermit-
tent hemolytic anemia, have been shown to be deficient in DAF (12, 13).
Recently, the cDNA encoding DAF has been cloned and sequenced, demonstrat-
ing the presence offour of the internal repeat unitscharacteristic ofthe C3b/C4b
binding proteins (14). DAF, therefore, shares functional and structural charac-
teristics with the subgroup of C3b/C4b binding proteins, C4bp, CRl, and H,
that function as regulators of the C3 convertases. To analyze the genetic
relationships of DAF with C4bp, CR 1, and H, we have searched for and found
restriction fragment length polymorphisms (RFLPs) for the DAF gene. We
demonstrate in this report that, in humans, the gene encoding DAF is closely
linked to the genes encoding CR1, C4bp, and H in the RCA gene cluster.
Materials and Methods
RCAAllotyping.
￿
Allotyping for protein variants of CR 1, C4bp, and H were performed
using erythrocytes and neuraminidase-treated EDTA-plasma or serum samples as previ-
ously described (15, 16). Additional discrimination between otherwise indistinguishable
CR1 variants was obtained through the analysis of previously described RFLPs for the
CR1 gene (17).
RFLP Analysis.
￿
The cloning of cDNAs encoding human DAF has revealed the exist-
ence oftwo classes of DAY mRNAs that apparently represent an alternative splicing event
involving the deletion of a 118-by-long intron (14). Sequence analysis of this fragment
showed an 80% homology with the Alu family consensus sequence (14). To avoid the
background hybridizations due to Alu sequences in the southern blot analysis of genomic
DNA, we have used a 2.1 kb DAY cDNA probe lacking the 118 by intron. This DAF
cDNA probe was a generous gift of Dr. I. Caras (Genentech, Inc., South San Francisco,
CA). In the analysis ofRFLPs of the CR1 gene, we have used the CR1-1 cDNA probe (7)
kindly provided by Dr. D. T. Fearon (Department of Medicine, Harvard Medical School,
Boston, MA).
Southern blot analyses were performed using genomic DNA digested with either Eco
RI, Bam HI, or Hind III restriction endonucleases (BRL, Bethesda, MD). 6,ug of digested
DNAs were electrophoresed for 30-40 h using 0.7% agarose gels in TAE buffer (Tris
acetate, 40 mM ; pH 7.2; EDTA 1 mM) and, after acid treatment, were transferred onto
Biotrace-RP nylon membranes (Gelman Sciences Inc ., Ann Arbor MI) in 0.4 M NaOH.
The membranes were hybridized with "P-labeled probes for 40 h at 65°C. Both the
prehybridization and hybridization solutions were: 5x SSC, 1 % SDS, 0.5% nonfat milk
powder, and 200 kg/ml of denatured salmon testes DNA. The blots were washed at 65'C
in 0.5X SSC, 1% SDS and exposed at -70°C on Kodak XAR-5 film using Cronex
Lightning Plus intensifying screens (DuPont Co., Wilmington, DE).
Results and Discussion
Bam HI and Hind III RFLPsfor DAF Gene.
￿
Southern blot analysis of human
genomic DNAs digested with either Barn HI or Hind III restriction endonu-
cleases and hybridized with the 2 .1 kb DAF cDNA probe (see Materials and
Methods) revealed the existence of genomic variants. The hybridization patterns
obtained with Barn HI disclosed two allelic fragments of 30 (allele S) and 35 kb
(allele L), and two invariant bands of 19 and 12 kb. The three expected Bam HI
patterns are illustrated in Fig. 1 . Individuals PED-3 and PED-8 are homozygotes
for the S allele. PED-6 and PED-7 are homozygotes for the L allele and all the
others are heterozygotes S, L.248
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FIGURE 1 .
￿
Bam HI RFLP for the DAF gene . Southern blot analysis of family PED showing
the three Bam HI polymorphic patterns for theDAF gene . Alleles ofthe polymorphic fragment
are indicated as S and L . Position of size markers corresponding to fragments generated by
separate digestions of X phage DNA with Kpn I, Hind III, Bst Ell, and Sma I restriction
enzymes is shown at left. Individual designations are givenabove the corresponding lanes .
FIGURE 2 .
￿
Hind III RFLPs for the DAF gene . Southern blot analysis of family DIF. The
Hind III-A polymorphic fragment alleles are indicated as Hind IIIA-1 and Hind IIIA-2 . The
Hind III-B polymorphic alleles are shown as Hind IIIB-1 andHind IIIB-2, respectively . Position
of size markers are indicated on the right side . Individual designations are given above the
corresponding lines.
Two independent RFLPs were found in genomic DNA digested with Hind
Ill . One of them, referred to as Hind III-A RFLP, has two allelic fragments of
9.8 (allele 1) and 7 .0 kb (allele 2), originating three Hind III patterns (Fig . 2) .
Individuals DIF-2, DIF-5, and DIF-7 are homozygotes for the 1 allele, while
DIF-9, DIF-10, and DIF-11 are homozygotes for the 2 allele, and all the others
are 1, 2 heterozygotes . The second Hind III RFLP, referred as Hind III-B
RFLP, corresponds to the presence or absence of a Hind III restriction site in a
13.9 kb fragment . The presence of this Hind III restriction site is designated as
allele 2 and determines two fragments, of 5 .5 and 8.4 kb, respectively . The
absence of this site, a 13.9 kb fragment, is designated as allele 1 . Homozygous
for the allele I are illustrated by individuals DIF-3, DIF-4, DIF-7, DIF-9, DIF-LOCI
DAF
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Family PED
￿
Family DIP
FIGURE 3.
￿
Segregation of the different alleles at the CRI, C4BP, and factor H loci and DAF
RFLPs in the two families. For each individual, typings have been organized so that each
column represents alleles inherited within the same haplotype. Two individuals (asterisk) have
inherited a C4BP, CRI1H recombinant haplotype (boxed) from one of their parents. In the
description of the CRI typings, A and A' or B and B' are only to indicate that these CRI
variants, indistinguishable at the protein level, can be differentiated by means of RFLP analysis,
as described in Materials and Methods.
10, and DIF-11 in Fig. 2, while all other individuals in Fig. 2, showing the three
bands of 13.9, 8.6, and 5.5 kb, are heterozygotes 1, 2. The third pattern,
corresponding to homozygous for theallele 2 (only the 8.6 and 5.5 kb fragments)
has not been found among the individuals studied here. In addition to the
polymorphic fragments describedabove, the Hind III restriction pattern includes
two invariant fragments, of 4.5 and 5.0 kb, respectively.
Variantsateach ofthese threepolymorphicsites are inherited inblock defining
restriction haplotypes. The use ofthe DAF restriction haplotypes increases our
ability to unravel different genetic variants at the DAF gene and thus facilitates
subsequent linkage analysis.
Genetic Linkage Between DAF and the RCA Gene Cluster.
￿
Because DAF resem-
bles C4bp, CR1, and H, we were interested in determining the genetic relation-
ships between them. C4bp and CRI are encoded by two loci within the RCA
gene cluster that appear to be very close together, since no recombinations have
been observed between them and since strong positive linkage disequilibrium
exists between their alleles (19). H is encoded by a third locus, H, at the RCA
gene cluster, which maps 6.9 cM away from the C4BP and CRI loci (19). As a
consequence of the linkage between C4BP, CRI, and H, alleles at these loci are
inherited as haplotypes (RCA haplotypes).
To determine whether the gene encoding DAF is linked to the RCA cluster,
we searched for families which, in addition to being informative for the segre-
gation of both the RCA haplotypes and the DAF restriction haplotypes, also
included individuals showing recombination within the RCA gene cluster. These
RCA-recombinanthaplotypeswould, in theevent oflinkage, provide information
ofthe position ofthe DAF gene within the RCA gene cluster. Two families, PED
and DIF, including a total of 16 offspring, were found to satisfy both require-
ments. The results of typing for alleles at the loci of the RCA gene cluster and
the DAF RFLPs for these families are summarized in Fig. 3. The individuals
PED-10 and DIF-6 each have inherited an intra-RCA recombination event
between CR1/C4BP and H from their respective parents, PED-1 and DIF-5. To
BamHl : SL LS SS SL SL LL LL SS SL S LS SL SS LS L9 99 SS L9 LL LL LL
Hind 111-A : 12 21 IS 12 12 22 22 11 12 21 21 12 11 21 21 11 21 S1 21 22 22 22
Hind III-B : 11 11 11 11 11 11 11 11 11 11 11 21 21 11 11 21 12 11 12 11 11 11
CRI AS AB AB AA AA SA BA AS AA BB AS AN BA' BA' AN A'A' BA Br Sr BB
C4BP 12 11 11 11 11 21 21 11 11 1211 21 SI 11 11 11 11 I1 11 It 12 12 11
H: 21 11 21 21 21 11 21 21 21 11 11 12 12 12 12 1 22 11 21 11 12
9F iF250
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simplify the formal analysis of linkage, the CR11C4BP portion of these RCA-
recombinant haplotypes was used as the marker.
All 32 meioses in these families were informative for the segregation of both
RCA and DAFhaplotypes, and no recombination was found between them. The
corresponding value for the Lod score (logarithm of odds in favor of linkage)
was 8.42 at a recombinant fraction value (9) of0.00 (likelihood in favor oflinkage
of 2.6 X 108 to 1). These results demonstrate that DAF is a member ofthe RCA
gene cluster. The two individuals (PED-10 and DIF-6) showing recombination
between H and CRI/C4BP loci allowed us to determine that DAF is genetically
separable from Hbut not from the CR11C4BP segment ofthe chromosome.
The demonstration of the linkage of DAF to the genes encoding CR1, C4bp,
and H supports the concept that the genes in the RCA cluster have evolved as a
cluster because of selective pressures related to the specific function of these
proteins. Thus, other C3b/C4b binding proteins involved in the regulation of
the C3-convertases, such as gp45/70 (20), mightalso be encoded by genes linked
to the RCA gene cluster.
The interesting possibility that proteins of the complement system with no
apparent functional relationships to the regulators of the C3 convertases may
also map within the RCA gene cluster has been recently raised. Thus, Weiss et
al. (7), have shown that both CRI and CR2 genes map to the same band (1g32)
on human chromosome 1 using labeled cDNAs in in situ hybridization experi-
ments. CRI and CR2 show strong structural homology, both at the protein and
DNA level, suggesting that they resulted from the divergence of relatively
recently duplicated genes (7). This degree of structural homology is exceptional
for the known members of the RCA complex which, in general, share only a
characteristic framework of highly conserved amino acid residues (8). The
linkage of CR1 and CR2, on the other hand, additionally suggests that the genes
encoding the related complement receptors, CR3 and CR4, might also be linked
and thus, within the RCA cluster. If they are indeed linked, RCA might, like
MHC, be a supergene complex, including genes that control distinct though
related functions through proteins that display varying levels of homology.
Summary
We have investigated the genetic relationships between the human decay-
accelerating factor (DAF) and a group ofcomplement components including the
C3b/C4b receptor (CR1), C4-binding protein (C4bp), and factor H(H), to which
DAF is structurally and functionally related. CRI, C4bp, and H were previously
demonstrated to be encoded by a cluster ofclosely linked genes, which we have
designated regulator of complement activation (RCA).
Southern blot analysis of genomic DNA using a DAF cDNA probe unraveled
the existence ofrestriction fragment length polymorphism (RFLP) for both Bam
HI and Hind III restriction endonucleases. Segregation analysis of these poly-
morphic fragments in families informative for the segregation ofalleles at the
CRI, C4BP, and H loci (RCA-haplotypes), demonstrated that, in humans, the
gene encoding DAF is located within the RCA gene cluster. No recombinants
between DAF and C4BP/CRI were encountered in 32 informative meioses. In
addition, in two individuals showing recombination between the CR11C4BP and
H loci, DAF segregated with the CR11C4BP segment. Thus, the DAF gene mapscloser to the CR1/C4BP loci than to the H gene, from which it can be separated
by genetic recombination.
We thank Mrs. C. Carrier and Mr. N . Mollen for their help in obtaining the DNA samples,
and Ms. T. Huima for the photographic work.
Receivedfor publication 9 February 1987.
REY-CAMPOS ET AL.
￿
25 1
Note added in proof . A Brief Definitive Report on a similar topicwas published by Lublin et al. (J.
Exp. Med. 165:1731, 1987).
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